Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.

In a nonprofit’s report released this week grading hospitals across the nation on overall performance in keeping patients safe from preventable harm and medical errors, Oroville Hospital received a D.

Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...

Considering taking supplements to treat clostridium difficile infection? Below is a list of common natural remedies used to treat or reduce the symptoms of clostridium difficile infection.

diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection is of a different strain. Clostridioides difficile ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk ...

NICE have found that the evidence supporting FMT for recurrent Clostridium difficile infection is sufficient for the procedure to be carried out. However, it is only considered when patients have ...

These studies have found that gut astrocytes are important regulators of mucosal barrier function and inflammation in inflammatory bowel disease, necrotizing enterocolitis and Clostridium difficile ...

Medically reviewed by Mary Choy, PharmD Probiotics are live microorganisms (microscopic living things such as bacteria, ...

The new hand gel, produced by Primel, being tested in Royal Preston Hospital Pic: Primel/Lancashire Teaching Hospitals A world-first in health-protecting ha ...